IgM and IgG Antibody Enzyme Linked Immunosorbent Assay Profile Detected Using Adult Schistosoma guineensis Extract In Sera from Cameroonian Infected by Schistosoma mansoni, Schistosoma haematobium and Schistosoma guineensis

hestopathoglogical studies on migration of schistosoma haematobium and schistosoma mansoni larvae in laboratory animals

in this paper the histopathological observation of the migratory phase of schistosome larvae (schistosomulae) in the laboratory animal were studied. the first tissue samples were taken from the skin of infected animals 30 minutes after exposure to the cercariae and continued daily up to 40 days post infection. the tissue specimens were taken from skin, liver. lung, lymph nodes, kidney, brain, b...

The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium.

The effect of praziquantel treatment on the age-antibody relationship was studied in 174 children aged between 6 and 17 years from a schistosome endemic area in Zimbabwe. The children were co-infected with Schistosoma mansoni and S. haematobium with infection prevalences of 74% and 53% respectively. Antibody levels for the isotypes IgA, IgE, IgM, IgG1, IgG2, IgG3 and IgG4, directed against solu...

Detection of Schistosoma mansoni and Schistosoma haematobium by Real-Time PCR with High Resolution Melting Analysis

The present study describes a real-time PCR approach with high resolution melting-curve (HRM) assay developed for the detection and differentiation of Schistosoma mansoni and S. haematobium in fecal and urine samples collected from rural Yemen. The samples were screened by microscopy and PCR for the Schistosoma species infection. A pair of degenerate primers were designed targeting partial regi...

In Vitro and In Vivo Activities of Arachidonic Acid against Schistosoma 1 mansoni and Schistosoma haematobium

In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium.

The development of arachidonic acid (ARA) for treatment of schistosomiasis is an entirely novel approach based on a breakthrough discovery in schistosome biology revealing that activation of parasite tegument-bound neutral sphingomyelinase (nSMase) by unsaturated fatty acids, such as ARA, induces exposure of parasite surface membrane antigens to antibody binding and eventual attrition of develo...